127 related articles for article (PubMed ID: 8395929)
1. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
2. Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET).
Taniuchi H; Fujibayashi Y; Okazawa H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1995 Aug; 18(8):1126-9. PubMed ID: 8535408
[TBL] [Abstract][Full Text] [Related]
3. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.
Fujibayashi Y; Taniuchi H; Wada K; Yonekura Y; Konishi J; Yokoyama A
Ann Nucl Med; 1995 Feb; 9(1):1-5. PubMed ID: 7779524
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic/microsomal redox pathway: a reductive retention mechanism of a PET-oncology tracer, cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (cu-PTSM).
Shibuya K; Fujibayashi Y; Yoshimi E; Sasai K; Hiraoka M; Welch MJ
Ann Nucl Med; 1999 Oct; 13(5):287-92. PubMed ID: 10582796
[TBL] [Abstract][Full Text] [Related]
5. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
[TBL] [Abstract][Full Text] [Related]
6. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
8. Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.
Okazawa H; Yonekura Y; Fujibayashi Y; Mukai T; Nishizawa S; Magata Y; Ishizu K; Tamaki N; Konishi J
J Nucl Med; 1996 Jul; 37(7):1089-93. PubMed ID: 8965175
[TBL] [Abstract][Full Text] [Related]
9. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
10. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
11. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
Green MA
Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
[TBL] [Abstract][Full Text] [Related]
12. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
13. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
Wong TZ; Lacy JL; Petry NA; Hawk TC; Sporn TA; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2008 Feb; 190(2):427-32. PubMed ID: 18212229
[TBL] [Abstract][Full Text] [Related]
14. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
Fujibayashi Y; Taniuchi H; Yonekura Y; Ohtani H; Konishi J; Yokoyama A
J Nucl Med; 1997 Jul; 38(7):1155-60. PubMed ID: 9225812
[TBL] [Abstract][Full Text] [Related]
15. Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography.
Herrero P; Markham J; Weinheimer CJ; Anderson CJ; Welch MJ; Green MA; Bergmann SR
Circulation; 1993 Jan; 87(1):173-83. PubMed ID: 8419005
[TBL] [Abstract][Full Text] [Related]
16. Generator-produced copper-62-PTSM as a myocardial PET perfusion tracer compared with nitrogen-13-ammonia.
Tadamura E; Tamaki N; Okazawa H; Fujibayashi Y; Kudoh T; Yonekura Y; Magata Y; Nohara R; Sasayama S; Konishi J
J Nucl Med; 1996 May; 37(5):729-35. PubMed ID: 8965135
[TBL] [Abstract][Full Text] [Related]
17. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
Green MA; Mathias CJ; Welch MJ; McGuire AH; Perry D; Fernandez-Rubio F; Perlmutter JS; Raichle ME; Bergmann SR
J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398
[TBL] [Abstract][Full Text] [Related]
18. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA
J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116
[TBL] [Abstract][Full Text] [Related]
19. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET.
Herrero P; Hartman JJ; Green MA; Anderson CJ; Welch MJ; Markham J; Bergmann SR
J Nucl Med; 1996 Aug; 37(8):1294-300. PubMed ID: 8708759
[TBL] [Abstract][Full Text] [Related]
20. The effects of glutathione depletion on the biodistribution of Cu(PTSM) in rats.
Barnhart-Bott A; Green MA
Int J Rad Appl Instrum B; 1991; 18(8):865-9. PubMed ID: 1800462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
